ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
34.68
-1.17%
US Tech 100
16,926.80
-2.21%
S&P 500
5,035.69
-1.57%
US Dollar vs CAD
1.37772
0.00%
Bitcoin
59,937.87
-1.09%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE
  6. Phaxiam Therapeutics (0QSS)

  7. Phaxiam Therapeutics (0QSS) News

0QSS

Phaxiam Therapeutics (0QSS)

Phaxiam Therapeutics
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:0QSS
DateTimeSourceHeadlineSymbolCompany
03/20/202412:00PMUK RegulatoryPHAXIAM Therapeutics publie ses résultats annuels 2023 et fait le point sur ses activitésLSE:0QSSPhaxiam Therapeutics
03/20/202412:00PMUK RegulatoryPHAXIAM Announces 2023 Full-Year Results and Provides Business UpdateLSE:0QSSPhaxiam Therapeutics
03/11/20241:00AMUK RegulatoryPHAXIAM Therapeutics announces effectiveness of voluntary delisting of American Depositary Shares from Nasdaq Stock MarketLSE:0QSSPhaxiam Therapeutics
03/11/20241:00AMUK RegulatoryPHAXIAM Therapeutics annonce la réalisation du retrait volontaire de ses « American Depository Shares » du Nasdaq Stock MarketLSE:0QSSPhaxiam Therapeutics
03/05/202411:00AMUK RegulatoryMonthly information related to total number of voting rights and shares composing the share capital - February 29, 2024LSE:0QSSPhaxiam Therapeutics
03/05/202411:00AMUK RegulatoryInformation mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 29 février 2024LSE:0QSSPhaxiam Therapeutics
02/20/20243:05PMUK RegulatoryPHAXIAM Therapeutics annonce son intention de procéder au retrait volontaire de ses « American Depositary Shares » du Nasdaq Capital MarketLSE:0QSSPhaxiam Therapeutics
02/20/20243:05PMUK RegulatoryPHAXIAM Therapeutics announces intention to voluntary delist American Depositary Shares from The Nasdaq Capital MarketLSE:0QSSPhaxiam Therapeutics
02/06/20243:05PMUK RegulatoryInformation mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 31 janvier 2024LSE:0QSSPhaxiam Therapeutics
02/06/20243:05PMUK RegulatoryMonthly information related to total number of voting rights and shares composing the share capital - January 31, 2024LSE:0QSSPhaxiam Therapeutics
 Showing the most relevant articles for your search:LSE:0QSS

Your Recent History

USOTC
YCRM
Yuenglings Ice Cream (PK)
USOTC
CBDW
1606 (PK)
USOTC
VXIT
Virexit Technologies (PK)
USOTC
ELTP
Elite Pharmaceuticals (QB)
COIN
BTCUSD
Bitcoin
USOTC
MCIC
Multicorp (PK)
USOTC
EGOC
Energy One (PK)
USOTC
BLFR
BlueFire Equipment (PK)
NASDAQ
AGBA
AGBA
USOTC
CBIA
Canopus Biopharma (PK)
NASDAQ
AMRN
Amarin
USOTC
CNNA
Cann American (CE)
NASDAQ
FCEL
FuelCell Energy
USOTC
TONR
Tonner One World (PK)
USOTC
BLEG
Branded Legacy (PK)
NYSE
AMC
AMC Entertainment
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved